{"pageContent": "Background: The U.S. Preventive Services Task Force recently concluded that the harms of existing prostate-specific antigen (PSA) screening strategies outweigh the benefits.", "metaData": {"source": "Hit by waves-living with local advanced or localized prostate cancer treated with endocrine therapy or under active surveillance\nhttps://pubmed.ncbi.nlm.nih.gov/20562621/"}}